Leslie Branch, MD
Plastic and Reconstructive Surgery · Winston Salem, NCNPI 1760777932
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 44.5% of the total.
Across 138 payments — averaging $38.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Mentor Worldwide LLC$619
- Integra Lifesciences Corporation$468
- TELA Bio, Inc.$201
- Stryker$180
- Baxter Healthcare$155
- plus $1K from 21 others
What the payments were for
- Food & beverage$5,02094%
- Other$3266%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 64 | $2,380 |
| Mentor Worldwide LLC | 12 | $619 |
| Integra Lifesciences Corporation | 7 | $468 |
| TELA Bio, Inc. | 7 | $201 |
| Stryker | 2 | $180 |
| Baxter Healthcare | 1 | $155 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $138 |
| Sientra, Inc. | 5 | $129 |
| Smith+Nephew | 6 | $116 |
| Pacira Pharmaceuticals Incorporated | 4 | $111 |
| TEI Biosciences Inc | 1 | $106 |
| Convatec Inc. | 2 | $94 |
| Kerecis Limited | 1 | $94 |
| Organogenesis Inc. | 3 | $78 |
| Tepha Inc | 1 | $66 |
| Heron Therapeutics, Inc. | 3 | $63 |
| Avanos Medical | 2 | $53 |
| Davol Inc. | 2 | $53 |
| Acera Surgical, Inc. | 2 | $48 |
| Vertex | 2 | $46 |
| Osiris Therapeutics Inc. | 2 | $30 |
| Acelrx Pharmaceuticals, Inc. | 2 | $27 |
| Acell, Inc. | 1 | $26 |
| Lifenet Health | 1 | $19 |
| Misonix Inc | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $14 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,346 in reported general payments places this provider in the 65th percentile of 55 plastic and reconstructive surgery providers in North Carolina.
See all plastic and reconstructive surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 19 | $124 |
| Oxycodone Hcl | 13 | $57 |
| Ibuprofen | 21 | $49 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Winston Salem
- Anne ArgentaWinston Salem$1K
- Adam PurzyckiWinston Salem$595
- Jeffrey MarcusDurham$3.3M
- Anuja AntonyCary$326K
- Peter ArnoldGreensboro$206K
- Joseph HunstadCharlotte$144K
- Charles HultmanRaleigh$70K
- Charles KaysWilmington$69K
- Brian CoanCary$41K
- Benjamin WoodRaleigh$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.